Search by Drug Name or NDC

    NDC 54859-0801-60 Tusnel 30; 400; 60 mg/1; mg/1; mg/1 Details

    Tusnel 30; 400; 60 mg/1; mg/1; mg/1

    Tusnel is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 54859-0801
    Product ID 54859-801_732630f4-d829-4cab-8834-74ce18a6f145
    Associated GPIs 43997303320325
    GCN Sequence Number 070554
    GCN Sequence Number Description guaifenesin/DM/pseudoephedrine TABLET 400-30-60 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 34129
    HICL Sequence Number 000222
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PSEUDOEPHEDRINE HCL
    Brand/Generic Brand
    Proprietary Name Tusnel
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan HBr, Guaifenesin, Pseudoephedrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 30; 400; 60
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 54859-0801-60 (54859080160)

    NDC Package Code 54859-801-60
    Billing NDC 54859080160
    Package 60 TABLET in 1 BOTTLE (54859-801-60)
    Marketing Start Date 2007-07-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL a8784c65-47a5-4b72-a85b-fb51cfd22c6c Details

    Revised: 12/2020